Roche Pharma Vietnam and Bright Future Fund launch Joining Hands for Her 2026

Roche Pharma Vietnam and the Bright Future Fund have unveiled their annual "Joining Hands for Her" campaign for 2026, marking the 13th year of collaboration. Every year, over 25,700 women in Vietnam are diagnosed with breast cancer, with approximately 10,600 losing their lives due to the disease. More than 60% of cases are diagnosed late, making treatment more challenging and outcomes poorer.

The campaign emphasizes the importance of early detection and routine breast cancer screening, particularly for women at higher risk. Nguyen Thi Xuyen, president of the Bright Future Fund, stated that screening and early detection are vital in the fight against breast cancer. She urged every woman to prioritize their health by making regular screenings a habit, aiming to enhance treatment outcomes.

Since its inception in 2013, the partnership with Roche Pharma Vietnam has screened over 80,000 high-risk women and trained 600 healthcare professionals. Burak Pekmezci, general manager of Roche Pharma Vietnam, expressed pride in the collaboration, noting its impact on breast cancer treatment. The 2026 campaign aligns with the National Action Plan on Breast Cancer Prevention and Control 2026-2035, issued by the Ministry of Health, which aims to increase public awareness of breast cancer prevention and expand access to screening and early detection.

Together, these efforts support a comprehensive pathway for breast cancer care, from awareness to timely diagnosis and innovative treatment. These collective efforts strive to achieve the plan's targets by 2035: diagnosing 60% of breast cancers early, providing a confirmed diagnosis within 60 days for women with suspicious findings, and ensuring 80% of breast cancer patients complete their full treatment course.